» Articles » PMID: 37470727

Radiation Injury and Gut Microbiota-based Treatment

Overview
Journal Protein Cell
Date 2023 Jul 20
PMID 37470727
Authors
Affiliations
Soon will be listed here.
Abstract

The exposure to either medical sources or accidental radiation can cause varying degrees of radiation injury (RI). RI is a common disease involving multiple human body parts and organs, yet effective treatments are currently limited. Accumulating evidence suggests gut microbiota are closely associated with the development and prevention of various RI. This article summarizes 10 common types of RI and their possible mechanisms. It also highlights the changes and potential microbiota-based treatments for RI, including probiotics, metabolites, and microbiota transplantation. Additionally, a 5P-Framework is proposed to provide a comprehensive strategy for managing RI.

Citing Articles

Microbiota and Radiotherapy: Unlocking the Potential for Improved Gastrointestinal Cancer Treatment.

Vucinic D, Redzovic A, Hauser G, Mikolasevic I Biomedicines. 2025; 13(2).

PMID: 40002939 PMC: 11852588. DOI: 10.3390/biomedicines13020526.


Integrative multi-omics analysis of radionuclide-induced intestinal injury reveals the radioprotective role of L-citrulline through histone H3-mediated Cxcl3.

Yang P, Bai H, Yan T, Xu X, Tang X, Song B J Transl Med. 2025; 23(1):180.

PMID: 39953550 PMC: 11829450. DOI: 10.1186/s12967-025-06197-9.


Colonic transendoscopic enteral tubing is revolutionizing intestinal therapeutics, diagnosis, and microbiome research.

Wang Z, Wu X, Wang Y, Wen Q, Cui B, Zhang F Therap Adv Gastroenterol. 2024; 17:17562848241301574.

PMID: 39582897 PMC: 11585053. DOI: 10.1177/17562848241301574.


Selenium Attenuates Radiation Colitis by Regulating cGAS-STING Signaling.

Xue Q, Lai H, Zhang H, Li G, Pi F, Wu Q Adv Sci (Weinh). 2024; 11(44):e2403918.

PMID: 39348242 PMC: 11600249. DOI: 10.1002/advs.202403918.


Global research trends on the links between gut microbiota and radiotherapy: a bibliometric analysis (2004-2023).

Wang S, Yuan Z, Gao X, Wu J, Ren Y, Yu X Front Cell Infect Microbiol. 2024; 14:1414196.

PMID: 39295732 PMC: 11409093. DOI: 10.3389/fcimb.2024.1414196.


References
1.
Deng F, Zhao B, Yang X, Lin Z, Sun Q, Wang Y . The gut microbiota metabolite capsiate promotes Gpx4 expression by activating to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes. 2021; 13(1):1-21. PMC: 8009132. DOI: 10.1080/19490976.2021.1902719. View

2.
Feuerstadt P, Louie T, Lashner B, Wang E, Diao L, Bryant J . SER-109, an Oral Microbiome Therapy for Recurrent Infection. N Engl J Med. 2022; 386(3):220-229. DOI: 10.1056/NEJMoa2106516. View

3.
Karaman B, Battal B, Sari S, Verim S . Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014; 20(47):18059-60. PMC: 4273161. DOI: 10.3748/wjg.v20.i47.18059. View

4.
Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1):55. PMC: 5754356. DOI: 10.1038/s41467-017-02490-4. View

5.
Bell B, Vercellino J, Brodin N, Velten C, Nanduri L, Nagesh P . Orthovoltage X-Rays Exhibit Increased Efficacy Compared with γ-Rays in Preclinical Irradiation. Cancer Res. 2022; 82(15):2678-2691. PMC: 9354647. DOI: 10.1158/0008-5472.CAN-22-0656. View